Correlation Between Vivani Medical and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vivani Medical and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivani Medical and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivani Medical and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Vivani Medical and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivani Medical with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivani Medical and Eupraxia Pharmaceuticals.
Diversification Opportunities for Vivani Medical and Eupraxia Pharmaceuticals
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vivani and Eupraxia is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Vivani Medical and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Vivani Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivani Medical are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Vivani Medical i.e., Vivani Medical and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vivani Medical and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Vivani Medical is expected to generate 2.88 times more return on investment than Eupraxia Pharmaceuticals. However, Vivani Medical is 2.88 times more volatile than Eupraxia Pharmaceuticals Common. It trades about 0.04 of its potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.04 per unit of risk. If you would invest 101.00 in Vivani Medical on August 31, 2024 and sell it today you would earn a total of 44.00 from holding Vivani Medical or generate 43.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 35.01% |
| Values | Daily Returns |
Vivani Medical vs. Eupraxia Pharmaceuticals Commo
Performance |
| Timeline |
| Vivani Medical |
| Eupraxia Pharmaceuticals |
Vivani Medical and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vivani Medical and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Vivani Medical and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivani Medical position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Vivani Medical vs. PepGen | Vivani Medical vs. Tyra Biosciences | Vivani Medical vs. Entrada Therapeutics | Vivani Medical vs. Pharvaris BV |
| Eupraxia Pharmaceuticals vs. Dogwood Therapeutics, | Eupraxia Pharmaceuticals vs. Enanta Pharmaceuticals | Eupraxia Pharmaceuticals vs. Enveric Biosciences | Eupraxia Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |